Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Jamin

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1995
[Biological surveillance of hormone substitution: relying on the plasma levels of estradiol or the products used?]C Jamin
Gynecologie, Obstetrique & Fertilite|October 30, 2001
[Does hormone replacement therapy prevent coronary disease?]C Jamin
Gynecologie, Obstetrique & Fertilite|March 29, 2003
[Hyperprolactinemia truths and falsehoods: how to distinguish, in the framework of infertility evaluation? C. Decanter and R. Wainer. Gynécol Obstét Fertil 2002;30:331-339]C Jamin
Gynecologie, Obstetrique & Fertilite|April 3, 2012
[Hormone replacement therapy: do we have to choose between breast and endometrial cancer?]C Jamin
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|March 2, 2012
[How to classify hormonal contraceptives?]C Jamin
Contraception, Fertilite, Sexualite (1992)|May 20, 1999
[After how long should hormone replacement therapy be interrupted?]C Jamin
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 7, 2000
[Contraception, hormone replacement therapy and myomas]C Jamin
Gynecologie, Obstetrique & Fertilite|January 5, 2002
[Evaluation of weight and morphotype of French women in gynecological consultation]C Jamin
Contraception, Fertilite, Sexualite|February 1, 1993
[High-dose progestational contraception: advantages]C Jamin
Contraception, Fertilite, Sexualite (1992)|February 1, 1993
[High-dose progestational contraception: advantages]C Jamin
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1995
[Biological surveillance of hormone substitution: relying on the plasma levels of estradiol or the products used?]C Jamin
Gynecologie, Obstetrique & Fertilite|October 30, 2001
[Does hormone replacement therapy prevent coronary disease?]C Jamin
Gynecologie, Obstetrique & Fertilite|March 29, 2003
[Hyperprolactinemia truths and falsehoods: how to distinguish, in the framework of infertility evaluation? C. Decanter and R. Wainer. Gynécol Obstét Fertil 2002;30:331-339]C Jamin
Gynecologie, Obstetrique & Fertilite|April 3, 2012
[Hormone replacement therapy: do we have to choose between breast and endometrial cancer?]C Jamin
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|March 2, 2012
[How to classify hormonal contraceptives?]C Jamin
Contraception, Fertilite, Sexualite (1992)|May 20, 1999
[After how long should hormone replacement therapy be interrupted?]C Jamin
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 7, 2000
[Contraception, hormone replacement therapy and myomas]C Jamin
Gynecologie, Obstetrique & Fertilite|January 5, 2002
[Evaluation of weight and morphotype of French women in gynecological consultation]C Jamin
Contraception, Fertilite, Sexualite|February 1, 1993
[High-dose progestational contraception: advantages]C Jamin
Contraception, Fertilite, Sexualite (1992)|February 1, 1993
[High-dose progestational contraception: advantages]C Jamin
Pageof 12